Image pharmaphorum Editor Market Access As FDA inspections return, upholding compliance and maintain... The pharmaceutical industry has long been highly regulated to help ensure quality and safety across all aspects of its business. Market Access The new European Unitary Patent system – What you need to kn... The proposed European unitary patent and unified patent court represents one of the largest changes to the European patent system in a generation. Sales & Marketing Making data work by delivering relevant content to HCPs Healthcare providers (HCPs) are facing a digital deluge and successive studies reveal that most messaging gets lost in the flood. The torrent of ill-directed communication and ill- Oncology Checkpoint inhibitors, Enhertu in spotlight as ASCO resumes ... Researchers also dove into socio-economic disparities in cancer care. Load more results
Market Access As FDA inspections return, upholding compliance and maintain... The pharmaceutical industry has long been highly regulated to help ensure quality and safety across all aspects of its business.
Market Access The new European Unitary Patent system – What you need to kn... The proposed European unitary patent and unified patent court represents one of the largest changes to the European patent system in a generation.
Sales & Marketing Making data work by delivering relevant content to HCPs Healthcare providers (HCPs) are facing a digital deluge and successive studies reveal that most messaging gets lost in the flood. The torrent of ill-directed communication and ill-
Oncology Checkpoint inhibitors, Enhertu in spotlight as ASCO resumes ... Researchers also dove into socio-economic disparities in cancer care.
News NHS risks missing out on independent prescriber benefits Gaps in support could undermine a wave of new independent prescribers entering the NHS and a push for more community-based care, warns a new report.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
